FDA Inspection 782814 — Celgene Corp
The FDA completed an inspection of Celgene Corp on May 3, 2012 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Overland Park, KS (United States)